Teladoc Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,530	2,570	2,602	2,407	2,033
Revenue Growth (YoY)	-1.54%	-1.26%	8.13%	18.41%	85.81%
Cost of Revenue	771.59	751.27	760.03	743.99	650.26
Gross Profit	1,758	1,818	1,842	1,663	1,382
Selling, General & Admin	1,280	1,346	1,367	1,301	1,105
Research & Development	277.92	307.27	348.52	333.63	311.88
Amortization of Goodwill & Intangibles	350.76	363.37	325.93	234.72	195.3
Operating Expenses	1,922	2,027	2,053	1,880	1,621
Operating Income	-163.4	-208.79	-210.5	-217.47	-238.99
Interest Expense	-19.71	-23.8	-22.28	-21.94	-81.14
Interest & Investment Income	36.77	57.07	46.78	12.67	0.78
Currency Exchange Gain (Loss)	-	-	-	-	-0.81
Other Non Operating Income (Expenses)	10.37	-6.04	4.45	-0.86	-
EBT Excluding Unusual Items	-135.97	-181.56	-181.56	-227.6	-320.17
Merger & Restructuring Charges	-27.8	-22.1	-38.05	-23.04	-26.64
Impairment of Goodwill	-71.76	-790	-	-13,403	-
Gain (Loss) on Sale of Investments	-	-	-	-	5.9
Asset Writedown	-	-	-	-9.9	-
Other Unusual Items	-	-	-	-	-43.75
Pretax Income	-235.53	-993.65	-219.61	-13,663	-384.66
Income Tax Expense	-35.21	7.59	0.76	-3.81	44.14
Net Income	-200.32	-1,001	-220.37	-13,660	-428.79
Net Income to Common	-200.32	-1,001	-220.37	-13,660	-428.79
Shares Outstanding (Basic)	176	171	165	161	157
Shares Outstanding (Diluted)	176	171	165	161	157
Shares Change (YoY)	3.32%	3.64%	1.93%	2.88%	73.40%
EPS (Basic)	-1.14	-5.87	-1.34	-84.60	-2.73
EPS (Diluted)	-1.14	-5.87	-1.34	-84.60	-2.73
Free Cash Flow	285.46	282.89	338.56	172.81	185.46
Free Cash Flow Per Share	1.62	1.66	2.06	1.07	1.18
Gross Margin	69.50%	70.76%	70.80%	69.09%	68.01%
Operating Margin	-6.46%	-8.13%	-8.09%	-9.04%	-11.76%
Profit Margin	-7.92%	-38.96%	-8.47%	-567.53%	-21.09%
Free Cash Flow Margin	11.28%	11.01%	13.01%	7.18%	9.12%
EBITDA	33.06	31.72	43.61	-7.54	-31.42
EBITDA Margin	1.31%	1.23%	1.68%	-0.31%	-1.55%
D&A For EBITDA	196.46	240.51	254.11	209.93	207.57
EBIT	-163.4	-208.79	-210.5	-217.47	-238.99
EBIT Margin	-6.46%	-8.13%	-8.09%	-9.04%	-11.76%
Advertising Expenses	648.48	693.21	673.55	609.45	397.77

Updated Feb 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q